These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8482063)
1. [Evaluation of the clinical efficacy of misoprostol for gastric cytoprotection in patients under treatment with NSAID after proctologic intervention]. Spaggiari L; Carbognani P; Rusca M; Dell'Abate P; Soliani P; Anelli D; Cattelani L; Foggi E Clin Ter; 1993 Mar; 142(3):235-41. PubMed ID: 8482063 [TBL] [Abstract][Full Text] [Related]
2. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL; Huang B; Amer F; Christopoulos NG Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480 [TBL] [Abstract][Full Text] [Related]
3. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group. Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107 [TBL] [Abstract][Full Text] [Related]
4. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation. Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455 [TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol. Koch M Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471 [TBL] [Abstract][Full Text] [Related]
9. Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial. La Torre F; Nicolai AP Dis Colon Rectum; 2004 May; 47(5):704-10. PubMed ID: 15037936 [TBL] [Abstract][Full Text] [Related]
10. [Cost effectiveness of misoprostol therapy in prevention of NSAID-induced stomach ulcers]. Schwarz B Wien Klin Wochenschr; 1995; 107(12):366-72. PubMed ID: 7631507 [TBL] [Abstract][Full Text] [Related]
11. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole. Bannwarth B; Dorval E; Caekaert A; Barthelemy P J Rheumatol; 2002 Sep; 29(9):1975-80. PubMed ID: 12233895 [TBL] [Abstract][Full Text] [Related]
12. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484 [TBL] [Abstract][Full Text] [Related]
13. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G; Lazzaroni M; Petrillo M Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [TBL] [Abstract][Full Text] [Related]
14. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs. Agrawal NM; Aziz K J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Pincus T; Koch GG; Sokka T; Lefkowith J; Wolfe F; Jordan JM; Luta G; Callahan LF; Wang X; Schwartz T; Abramson SB; Caldwell JR; Harrell RA; Kremer JM; Lautzenheiser RL; Markenson JA; Schnitzer TJ; Weaver A; Cummins P; Wilson A; Morant S; Fort J Arthritis Rheum; 2001 Jul; 44(7):1587-98. PubMed ID: 11465710 [TBL] [Abstract][Full Text] [Related]
16. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol. Goldstein JL; Larson LR; Yamashita BD Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial. Simon LS; Hatoum HT; Bittman RM; Archambault WT; Polisson RP Fam Med; 1996 Mar; 28(3):204-10. PubMed ID: 8900554 [TBL] [Abstract][Full Text] [Related]